CLOSE

Subscribe to email alerts

Embark Health 21/04/2021

Embark Delta Inc. Completes New Product Shipment to Province of British Columbia

Toronto, Ontario – April 20, 2021 – Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. (“Embark” or the “Company”) is pleased to announce the Company has successfully completed its second shipment of products to the British Columbia Liquor Distribution Branch (“BCLDB”), with Distilled + Infused Liquid Beverage Shots.

Distilled + Infused is Embark’s inaugural product offering in the beverage category. The suite of products under the Distilled + Infused brand are produced through Embark Nano’s ground-breaking technology. The THC-infused Liquid Beverage Shot comes in an unflavoured option, which can be enjoyed with an adult’s drink of choice. It also comes in strawberry lemonade and raspberry lemonade flavours which are naturally-flavoured. Packaged in a convenient “grab and go” option, all varieties contain Embark Nano’s proprietary bitter blocker, which eliminates any bitter taste typically found in current market offerings. When combined with your preferred drink, the Liquid Beverage Shot results in a clear, translucent blend that won’t compromise taste or flavour and requires no stirring. The Distilled + Infused Liquid Beverage Shot is ideal for those who desire an alternative to traditional cannabis consumption or beverage alternative to alcoholic beverages.

As with any alcoholic beverage and cannabis product, we recommend responsible consumption.


About Embark Health Inc.

Embark Health Inc. is a leader in solventless cannabis extraction, with a focus on the formulation and production of advanced 2.0 products for the B2B, medical, and adult-use markets. Embark continues to be at the forefront of production of concentrate products including bubble hash, traditional pressed hash, rosin, and dry sift. Building on Embark’s strength in innovation and creating industry leading Cannabis 2.0 products, it recently announced new product offerings through its proprietary ground-breaking Embark Nano technology. The new suite of products coming to market include cannabis-infused beverages, topicals, edibles and water-soluble powders.
 
It is Embark’s mandate to pursue best-in-class production processes resulting in premium quality commercial and consumer extraction products. Embark Health Inc. is dedicated to unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. For more information, please visit www.embarkhealthinc.com.

Back to News

Related Articles

Embark Health

Embark Health Investor Update

19/03/2019 Read more
Embark Health

Embark Health Investor Quarterly Update

16/08/2019 Read more
Embark Health

MMJ Group increases investment in Embark Health, valuation nearly triples

17/10/2019 Read more
Embark Health

Embark Health – Corporate Presentation November 2019

07/11/2019 Read more

CLOSE

Subscribe to email alerts